NF-kappa-B essential modulator–IkappaB kinase complex interface (NEMO–IKK interface)

The NEMO–IKK complex interface is a pivotal protein-protein interaction (PPI) site essential for the activation of the canonical NF-kappa-B (NF-κB) signaling pathway. This interface is formed by the association of the regulatory subunit, NF-kappa-B essential modulator (NEMO, also known as IKK-gamma), with the C-terminal NEMO-binding domain (NBD) of the catalytic subunits, IKK-alpha and IKK-beta [PMID: 11009534]. Assembly of this complex is a prerequisite for the phosphorylation of IkappaB proteins, which normally sequester NF-κB in the cytoplasm; upon phosphorylation, IkappaB is degraded, allowing NF-κB to translocate to the nucleus and initiate gene transcription [PMID: 15123770]. Because constitutive NF-κB activation is a hallmark of many inflammatory disorders and cancers, the NEMO–IKK interface has emerged as a high-value therapeutic target [PMID: 24037311]. Small molecules and cell-permeable peptides, such as the NBD peptide, have been developed to competitively inhibit this interaction, thereby selectively blocking induced NF-κB activation while potentially sparing basal activity [PMID: 18462254]. However, therapeutic challenges include the risk of systemic immunosuppression and the difficulty of targeting PPIs with high-affinity small molecules [PMID: 21151045].

Other names

IKK-gamma–IKK-alpha/beta interfaceNBD–NEMO interactionIKK complex assembly interfaceNEMO-binding domain interface

Competitive inhibition of the interaction between the NEMO-binding domain (NBD) of IKK-alpha/beta and the N-terminal alpha-helical region of NEMO, preventing the formation of a functional IKK complex.